Insider Transactions in Q3 2025 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2025
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
3,836
-10.86%
|
$1,603,448
$418.84 P/Share
|
|
Sep 04
2025
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,084
-16.7%
|
$2,911,524
$411.59 P/Share
|
|
Sep 04
2025
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,920
+20.47%
|
$1,889,160
$173.12 P/Share
|
|
Jul 29
2025
|
John Chidsey |
BUY
Grant, award, or other acquisition
|
Direct |
496
+50.0%
|
-
|